as on October 29, 2025 at 1:29 am IST
Day's Low
Day's High
11.96%
Downside
3.04%
Upside
52 Week's Low
52 Week's High
67.15%
Downside
-12.61%
Upside
Check Arcutis Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.4B
EPS (TTM)
-0.4483
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.47
Industry PE ratio
-0.8809294871794872
PEG Ratio
0EBITDA
-80.1M
Revenue (TTM)
263.5M
Profit Margin
-35.40%
Return On Equity TTM
-57.33%
Track how Arcutis Biotherapeutics Inc P/E has moved over time to understand its valuation trends.
Arcutis Biotherapeutics Inc in the last 5 years
Lowest (-37.55x)
September 30, 2025
Today (-6.47x)
October 28, 2025
Industry (-0.88x)
October 28, 2025
Highest (-0.69x)
December 31, 2023
Today’s Price to Earnings Ratio: -6.47x
Compare market cap, revenue, PE, and other key metrics of Arcutis Biotherapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.4B | -2.43% | -6.47 | -35.40% | |
| BUY | $60.7B | 283.23% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $108.0B | 101.68% | 29.95 | 31.86% | |
| BUY | $61.3B | 3.22% | 14.55 | 31.37% |
The Arcutis Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arcutis Biotherapeutics Inc investment value today
Current value as on today
₹2,92,043
Returns
₹1,92,043
(+192.04%)
Returns from Arcutis Biotherapeutics Inc Stock
₹1,86,912 (+186.91%)
Dollar Returns*
₹5,132 (+5.13%)
Based on 13 analysts
76.92%
Buy
23.08%
Hold
0.00%
Sell
Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Arcutis Biotherapeutics Inc. Average target price of $23.38
Get share price movements and forecasts by analysts on Arcutis Biotherapeutics Inc.
What analysts predicted
-6.89%DOWNSIDE
Target Price
$23.38
Current Price
$24.99
Analyzed by
13 Analysts
Target
$23.38
Arcutis Biotherapeutics Inc target price $23.38, a slight downside of -6.89% compared to current price of $24.99. According to 13 analysts rating.
Search interest for Arcutis Biotherapeutics Inc Stock has increased by 219% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:219% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -25.06M → -15.88M (in $), with an average increase of 57.8% per quarter
Price Rise
![]()
In the last 1 year, ARQT stock has moved up by 129.4%
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 65.84M → 81.50M (in $), with an average increase of 19.2% per quarter
Best in 1 Year
![]()
In the last 1 year, ARQT has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 134.0% return, outperforming this stock by 121.8%
| Organisation | Arcutis Biotherapeutics Inc |
| Headquarters | 3027 Townsgate Road, Westlake Village, CA, United States, 91361 |
| Industry | Health Technology |
| CEO | Mr. Todd Franklin Watanabe M.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Rajvir Madan | Chief Digital & Technology Officer |
Mr. Steve Arias | Vice President of Compliance & Privacy |
Mr. Kent Taylor | Senior Vice President of Sales |
Mr. Todd Franklin Watanabe M.A. | President, CEO & Director |
Dr. Bhaskar Chaudhuri Ph.D. | Co-Founder & Independent Director |
Mr. Masaru Matsuda Esq., J.D. | Senior VP, General Counsel & Corporate Secretary |
Mr. Larry Todd Edwards | Executive VP & Chief Commercial Officer |
Dr. Patrick E. Burnett M.D., Ph.D. | Executive VP & Chief Medical Officer |
Ms. Latha Vairavan | Chief Financial Officer |
Ms. Amanda Sheldon | Head of Corporate Communications |
Arcutis Biotherapeutics Inc share price today is $24.99 as on at the close of the market. Arcutis Biotherapeutics Inc share today touched a day high of $25.75 and a low of $22.
Arcutis Biotherapeutics Inc share touched a 52 week high of $21.84 on and a 52 week low of $8.21 on . Arcutis Biotherapeutics Inc stock price today i.e. is closed at $24.99,which is -14.42% down from its 52 week high and 204.38% up from its 52 week low.
Arcutis Biotherapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Arcutis Biotherapeutics Inc (ARQT) shares with as little as ₹88.237 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.37 in Arcutis Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcutis Biotherapeutics Inc share’s latest price of $24.99 as on October 29, 2025 at 1:29 am IST, you will get 0.4002 shares of Arcutis Biotherapeutics Inc. Learn more about
fractional shares .
Arcutis Biotherapeutics Inc stock has given -2.43% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?